Correlation Between Brainstorm Cell and UPM Kymmene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brainstorm Cell and UPM Kymmene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brainstorm Cell and UPM Kymmene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brainstorm Cell Therapeutics and UPM Kymmene Oyj, you can compare the effects of market volatilities on Brainstorm Cell and UPM Kymmene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brainstorm Cell with a short position of UPM Kymmene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brainstorm Cell and UPM Kymmene.

Diversification Opportunities for Brainstorm Cell and UPM Kymmene

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Brainstorm and UPM is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Brainstorm Cell Therapeutics and UPM Kymmene Oyj in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UPM Kymmene Oyj and Brainstorm Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brainstorm Cell Therapeutics are associated (or correlated) with UPM Kymmene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UPM Kymmene Oyj has no effect on the direction of Brainstorm Cell i.e., Brainstorm Cell and UPM Kymmene go up and down completely randomly.

Pair Corralation between Brainstorm Cell and UPM Kymmene

If you would invest  269.00  in Brainstorm Cell Therapeutics on September 19, 2024 and sell it today you would earn a total of  0.00  from holding Brainstorm Cell Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy50.0%
ValuesDaily Returns

Brainstorm Cell Therapeutics  vs.  UPM Kymmene Oyj

 Performance 
       Timeline  
Brainstorm Cell Ther 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brainstorm Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
UPM Kymmene Oyj 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UPM Kymmene Oyj has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Brainstorm Cell and UPM Kymmene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brainstorm Cell and UPM Kymmene

The main advantage of trading using opposite Brainstorm Cell and UPM Kymmene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brainstorm Cell position performs unexpectedly, UPM Kymmene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UPM Kymmene will offset losses from the drop in UPM Kymmene's long position.
The idea behind Brainstorm Cell Therapeutics and UPM Kymmene Oyj pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation